David Heidary

David Heidary is a Research Professor at North Carolina State University, specializing in inorganic chemistry with a focus on photoactive metal complexes and their applications in cancer therapy. His work bridges medicinal chemistry, enzymology, and molecular biology, particularly targeting cytochrome P450 enzymes and developing light-activated anticancer agents.

Key research areas include:

• Design of ruthenium-based anticancer drugs with photodynamic properties
• Structure-activity relationships of metal complexes for targeted therapies
• Enzyme inhibition strategies for cancer treatment
• Development of fluorescent probes for cellular imaging

Recent studies emphasize dual-action compounds combining enzyme inhibition and DNA/RNA targeting. His work has advanced light-activated drug delivery systems and improved understanding of hypoxic tumor responses. Dr. Heidary collaborates extensively with biochemists and clinicians to translate fundamental discoveries into clinical applications.

Publications (2021-2025) highlight advancements in:

• Photocaged enzyme regulators
• Mitochondrial dysfunction mechanisms
• Subcellular localization of molecular rotors
• CYP1B1/P450 inhibition strategies

No specific awards or grants are explicitly mentioned in the provided text.